Topic: Medicines safety and preventable harm: a health economics perspective

Speaker: Professor Rachel A Elliott, Professor of Health Economics Centre Lead, Manchester Centre for Health Economics

Abstract

The economic impact of suboptimal medication use has motivated most health systems to develop strategies and interventions such as those that change prescribing or monitoring behaviour, and medicines-taking. These are often costly, with variable evidence of effectiveness or cost-effectiveness. The real impact of these interventions is often uncertain, as behaviour may not change as anticipated, or clinical and economic effects of most errors may be minor, or not understood. In an increasingly financially constrained healthcare environment, it is essential to be clearer about the true economic impact of interventions to improve medicines use. The role of digital and remote technology in supporting medicines safety is expanding, but successful implementation depends upon tailoring interventions to practice settings, patients, disease conditions, and treatment regimens and supporting all users to engage effectively with the digital services provided.

This seminar aims to examine the role of health economics in supporting medicines safety.

Case studies will be used to illustrate key issues in patient safety and hazardous prescribing: (the PINCER intervention) and effects of interoperability on patient safety: (information standard ISN DAPB4013: Medicine and Allergy/Intolerance Data Transfer to patients and the NHS in England). The approaches to assessing cost-effectiveness of strategies to improve medication safety is examined, looking at challenges, focusing on challenges in this field.

Date and Time: Wednesday 15 May, 12.30pm – 1.30pm

Venue: Online via Zoom

To book your place, please click here